|
Name |
Cyclohexyldimethoxymethylsilane
|
Molecular Formula | C9H20O2Si | |
IUPAC Name* |
cyclohexyl-dimethoxy-methylsilane
|
|
SMILES |
CO[Si](C)(C1CCCCC1)OC
|
|
InChI |
InChI=1S/C9H20O2Si/c1-10-12(3,11-2)9-7-5-4-6-8-9/h9H,4-8H2,1-3H3
|
|
InChIKey |
SJJCABYOVIHNPZ-UHFFFAOYSA-N
|
|
Synonyms |
17865-32-6; Cyclohexyldimethoxymethylsilane; Cyclohexyldimethoxy(methyl)silane; Cyclohexyl(dimethoxy)methylsilane; cyclohexyl-dimethoxy-methylsilane; Cyclohexylmethyldimethoxysilane; Silane, cyclohexyldimethoxymethyl-; Cyclohexane, (dimethoxymethylsilyl)-; Methylcyclohexyldimethoxysilane; cyclohexyl(methyl)dimethoxysilane; cyclohexyl methyl dimethoxy silane; CM8650; EC 402-140-1; SCHEMBL21032; cyclohexyldimethoxymethyl silane; CHMS 112; SJJCABYOVIHNPZ-UHFFFAOYSA-; cyclohexyl dimethoxy methyl silane; DTXSID40864805; Methyl-cyclohexyl-dimethoxy-silane; Cyclohexyl(dimethoxy)methylsilane #; ACT09142; AMY39312; MFCD00071752; AKOS008901356; ZINC169744937; METHYL CYCLOHEXYL DIMETHOXY SILANE; DB-044339; C1982; FT-0624214; F71182; S05200; J-011391
|
|
CAS | 17865-32-6 | |
PubChem CID | 569301 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 188.34 | ALogp: | 2.7 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 18.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 12 | QED Weighted: | 0.631 |
Caco-2 Permeability: | -4.303 | MDCK Permeability: | 0.00002620 |
Pgp-inhibitor: | 0.018 | Pgp-substrate: | 0.469 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.154 |
30% Bioavailability (F30%): | 0.011 |
Blood-Brain-Barrier Penetration (BBB): | 0.121 | Plasma Protein Binding (PPB): | 95.06% |
Volume Distribution (VD): | 0.943 | Fu: | 2.09% |
CYP1A2-inhibitor: | 0.311 | CYP1A2-substrate: | 0.941 |
CYP2C19-inhibitor: | 0.173 | CYP2C19-substrate: | 0.924 |
CYP2C9-inhibitor: | 0.108 | CYP2C9-substrate: | 0.809 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.88 |
CYP3A4-inhibitor: | 0.075 | CYP3A4-substrate: | 0.182 |
Clearance (CL): | 4.626 | Half-life (T1/2): | 0.334 |
hERG Blockers: | 0.089 | Human Hepatotoxicity (H-HT): | 0.076 |
Drug-inuced Liver Injury (DILI): | 0.055 | AMES Toxicity: | 0.103 |
Rat Oral Acute Toxicity: | 0.027 | Maximum Recommended Daily Dose: | 0.022 |
Skin Sensitization: | 0.451 | Carcinogencity: | 0.066 |
Eye Corrosion: | 0.994 | Eye Irritation: | 0.994 |
Respiratory Toxicity: | 0.187 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001186 | 0.383 | D03DVJ | 0.333 | ||||
ENC000492 | 0.356 | D07GRH | 0.250 | ||||
ENC000644 | 0.333 | D04URO | 0.237 | ||||
ENC001169 | 0.304 | D04JPJ | 0.230 | ||||
ENC001222 | 0.288 | D08MRN | 0.222 | ||||
ENC000183 | 0.282 | D07XJM | 0.215 | ||||
ENC001283 | 0.269 | D0N4PZ | 0.212 | ||||
ENC000170 | 0.255 | D0D1MA | 0.212 | ||||
ENC001167 | 0.254 | D0OK5I | 0.210 | ||||
ENC001191 | 0.250 | D0W8SB | 0.195 |